英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
flushness查看　flushness　在百度字典中的解释百度英翻中〔查看〕
flushness查看　flushness　在Google字典中的解释Google英翻中〔查看〕
flushness查看　flushness　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Frontiers | Benefits of SGLT2 inhibitors in patients with . . .
    SGLT2 inhibitors have transformed the care of patients with diabetes, chronic kidney disease (CKD), and cardiovascular disease Nevertheless, the efficacy of
  • 11. Chronic Kidney Disease and Risk Management: Standards of . . .
    Moreover, recent data support the notion that SGLT2 inhibitors reduce oxidative stress in the kidney by >50% and blunt increases in angiotensinogen as well as reduce NLRP3 inflammasome activity (92–94) Glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) have also been shown to improve kidney outcomes (95–100)
  • SGLT2 Inhibitors: What They Are, Uses Side Effects
    SGLT2 inhibitors lower blood sugar by causing your kidneys to remove glucose through your pee Learn more about this treatment for Type 2 diabetes
  • Cardiometabolic and renal benefits of sodium–glucose . . .
    In the past decade, the therapeutic scope of sodium–glucose cotransporter 2 (SGLT2) inhibitors has expanded beyond glycaemic regulation in the management of type 2 diabetes mellitus In this
  • Impact of diabetes on the effects of sodium glucose co . . .
    In addition to the established cardiovascular benefits of SGLT2 inhibitors, the randomised data support their use for modifying risk of kidney disease progression and acute kidney injury, not only in patients with type 2 diabetes at high cardiovascular risk, but also in patients with chronic kidney disease or heart failure irrespective of diabetes status, primary kidney disease, or kidney
  • Vascular effects of SGLT2 inhibitors: evidence and mechanisms
    In the experimental angiotensin II-induced hypertension model, vascular SGLT2 expression has been reported to be induced This effect was reversed by empagliflozin treatment, which normalized oxidative stress, inflammatory markers, and local components of the renin-angiotensin system activity in both the aorta and resistance vessels (63)
  • SGLT2 Inhibitors for the Management of IgA . . . - KidneyNews
    "SGLT2 Inhibitors for the Management of IgA Nephropathy: A New Therapeutic Paradigm for an Old Entity?" published on Feb 2022 by American Society of Nephrology
  • SGLT2 Inhibitor Shows Promise as a Treatment for PLN . . .
    The team of Cardiovascular Institute researchers considered that SGLT2 inhibitors could be a potential therapy SGLT2s are a class of drugs originally developed to treat type 2 diabetes
  • Phenotype-based targeted treatment of SGLT2 inhibitors and . . .
    Given the lack of evidence to support targeted treatment of SGLT2i compared with GLP1-RA therapies, we aimed to develop and validate a prediction model to provide individual patient-level estimates of differences in 12-month glycaemic (HbA 1c) outcomes for the two drug classes based on routinely collected clinical features
  • Overcoming Barriers to Use of SGLT2 Inhibitor Therapy: The . . .
    Multiple large randomized clinical trials have confirmed sodium-glucose cotransporter-2 (SGLT2) inhibitors as highly efficacious therapy for patients with heart failure (HF) across the spectrum of ejection fraction (EF) Robust clinical benefits occur within days to weeks of SGLT2 inhibitor initiation, are fully additive to other elements of guideline-directed medical therapy (GDMT), and are





中文字典-英文字典  2005-2009